-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

102. Regulation of Iron Metabolism: Poster II

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, Anemias, Biological, aplastic anemia, Diseases, Non-Biological, Bone Marrow Failure, Therapies, Genetic Disorders, Biological Processes, enzyme inhibitors, iron deficiency, Polycythemia vera, Technology and Procedures, erythropoiesis, Study Population, Clinically relevant, Myeloid Malignancies, hematopoiesis, pharmacology, iron metabolism, iron transport, serologic tests
Sunday, December 6, 2020: 7:00 AM-3:30 PM

David J Young, MD, PhD1, Xing Fan, MD2*, Emma Groarke, MD3*, Bhavisha A Patel, MD3, Ronan Desmond, MD3,4, Thomas Winkler, MD1, Andre Larochelle, MD, PhD5, Katherine Calvo, MD, PhD6, Neal S. Young, MD3 and Cynthia E. Dunbar, MD2

1Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
2Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, National Institute of Health, Bethesda, MD
3Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
4Department of Haematology, Tallaght University Hospital, Dublin, Ireland
5Laboratory of Regenerative Therapies for Inherited Blood Disorders, Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD
6Hematology Section, Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD

Yelena Ginzburg, MD1, Marina Kremyanskaya2, Andrew T. Kuykendall, MD3, Abdulraheem Yacoub, MD4, Jay Yang, MD5, Suneel K Gupta, PhD6*, Frank Valone, MD7*, Sarita Khanna, PhD8*, Ronald Hoffman, MD9 and Srdan Verstovsek, MD, PhD10

1Division of Hematology Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
2Division of Hematology/Medical Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY
3Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
4The University of Kansas Cancer Center, Leawood, KS
5Karmanos Cancer Institute, Detroit, MI
6Protagonist Therapeutics, Sunnyvale, CA
7Protagonist Therapeutics, Mill Valley, CA
8Protagonist Therapeutics, Newark, CA
9Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
10Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Vu Hong, PhD1*, Ravi Krishna Babu, PhD2*, Cecile Blaustein, PhD1*, Sophia Nguyen, MS1*, Venkateshwar Rao, PhD2*, Will Savage, MD, PhD1, Brian MacDonald, PhD, MBBChir, MRCP1*, Maria G. Beconi, PhD, MS1* and Srikanth Venkatraman, PhD1*

1Disc Medicine, Cambridge, MA
2Aurigene Discovery Technologies, Bangalore, India

Michael Auerbach, MD, FACP1, Carlo Brugnara, MD2,3 and Steve Staffa, PhD4*

1Medicine, Georgetown University School of Medicine, Baltimore, MD
2Department of Laboratory Medicine, Harvard Medical School, Boston Children's Hospital, Boston, MA
3Department of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA
4Anesthesiology, Boston Children's Hospital, Boston, MA

Veena Sangkhae, PhD1*, Tomas Ganz, MD, PhD2 and Elizabeta Nemeth, PhD3

1Center for Iron Disorders, University of California Los Angeles, Los Angeles, CA
2Center for Iron Disorders, University of California, Los Angeles, Los Angeles, CA
3Center for Iron Disorders, David Geffen School of Medicine at UCLA, Los Angeles, CA

Giovanna Graziadei, MD1*, Lorena Duca, MSc1*, Francesca Granata, MSc1*, Giacomo De Luca, MD1,2*, Valentina Brancaleoni, MSc1*, Isabella Nava, MSc1*, Dario Tavazzi, MSc3*, Silvia Fustinoni, PhD3,4* and Elena Di Pierro, PhD1*

1UOC Medicina Generale, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
2Università degli studi di Milano, Milan, Italy
3Dip. Scienze Cliniche e di Comunità, Università degli studi di Milano, Milan, Italy
4UOC Medicina del Lavoro, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy

Jenny Sumin Yoon, MBChB1*, Ross Alistair Henderson, MBChB FRACP FRCPA PhD1*, Merit Hanna, MBChB FRCPA1*, Eileen Merriman, MBChB BMLSc FRACP FRCPA PhD1,2*, Anna Elinder, MBChB FRACP FRCPA1,2*, Gilly Selman, MLS1*, Leone Kennedy, BN PGCertHSc1* and Henry Chan, MBChB, FRACP, FRCPA1,2

1Department of Haematology, Waitemata District Health Board, Auckland, New Zealand
2Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand

*signifies non-member of ASH